# Safety and Acceptability of Carraguard® in HIV Positive Women and Men

> **NCT00213005** · PHASE1 · COMPLETED · sponsor: **Population Council** · enrollment: 60 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Carraguard (PC-515)

## Key facts

- **NCT ID:** NCT00213005
- **Lead sponsor:** Population Council
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06
- **Primary completion:** —
- **Final completion:** 2003-08
- **Target enrollment:** 60 (—)
- **Last updated:** 2017-08-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00213005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00213005, "Safety and Acceptability of Carraguard® in HIV Positive Women and Men". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00213005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*